Ballentine Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
Ballentine Partners's CAH Position: Q3 2026 in Review
Ballentine Partners increased its Cardinal Health (CAH) stake by 5.6% in Q3 2026, buying an estimated $74.9K and bringing the position to 6,026 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #319.
Ballentine Partners first reported a position in CAH in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.36M in Q2 2026. 1,496 funds tracked by Wall St. Rank hold CAH as of Q3 2026.
- Ballentine Partners held 6,026 shares of Cardinal Health worth $1.34M as of Q3 2026.
- Ballentine Partners bought 322 Cardinal Health shares in Q3 2026, an estimated $74.9K.
- Cardinal Health made up 0.02% of Ballentine Partners's portfolio in Q3 2026, its #319 holding.
- Ballentine Partners first reported a position in Cardinal Health in Q1 2022 and has held it in 14 quarters since.
- Ballentine Partners's Cardinal Health position peaked at $1.36M in Q2 2026.
- 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.
Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.